WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (61)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vallebuona, F.
Right arrow Articles by Raiteri, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vallebuona, F.
Right arrow Articles by Raiteri, M.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 14, 134-139, Copyright © 1994 by Society for Neuroscience


ARTICLE

Extracellular cGMP in the hippocampus of freely moving rats as an index of nitric oxide (NO) synthase activity

F Vallebuona and M Raiteri
Institute of Pharmacology and Pharmacognosy, University of Genova, Italy.

The nitric oxide (NO) synthase/cGMP pathway has been studied in vivo in the adult rat hippocampus by monitoring the levels of extracellular cGMP during microdialysis in conscious unrestrained animals. The basal cGMP efflux was concentration-dependently reduced upon local infusion of the NO synthase inhibitor NG-nitro-L-arginine (NARG; 10 microM to 1 mM). The NO donors hydroxylamine and S-nitroso-N-penicillamine, perfused through the dialysis probe at 1 mM, increased by about 200% the extracellular levels of cGMP. The glutamate receptor agonist NMDA (125-500 microM) produced concentration-dependent cGMP responses that were abolished by the selective receptor antagonist D-2-amino-5- phosphonovaleric acid or by NARG. Local perfusion of the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX; 1 mM) produced a steady eightfold increase of extracellular cGMP levels. The effect of IBMX was highly sensitive to NARG. The inhibition by NARG of the IBMX-induced cGMP response was reversed when the NO synthase substrate L-arginine was administered. It is concluded that cGMP collected during in vivo microdialysis reflects NO synthase activity in the rat hippocampus. The technique may be utilized to investigate the pathophysiology and the pharmacology of the NO/cGMP pathway in the hippocampus of living animals.


This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
M. Raiteri
Functional pharmacology in human brain.
Pharmacol. Rev., June 1, 2006; 58(2): 162 - 193.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. U. Suvarna and J. M. O'Donnell
Hydrolysis of N-Methyl-D-aspartate Receptor-Stimulated cAMP and cGMP by PDE4 and PDE2 Phosphodiesterases in Primary Neuronal Cultures of Rat Cerebral Cortex and Hippocampus
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 249 - 256.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Goyagi, S. Goto, A. Bhardwaj, V. L. Dawson, P. D. Hurn, and J. R. Kirsch
Neuroprotective Effect of {{sigma}}1-Receptor Ligand 4-Phenyl-1-(4-Phenylbutyl) Piperidine (PPBP) Is Linked to Reduced Neuronal Nitric Oxide Production
Stroke, July 1, 2001; 32(7): 1613 - 1620.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
U. Lindauer, D. Megow, H. Matsuda, and U. Dirnagl
Nitric oxide: a modulator, but not a mediator, of neurovascular coupling in rat somatosensory cortex
Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H799 - H811.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Bhardwaj, M. Sawada, E. D. London, R. C. Koehler, R. J. Traystman, J. R. Kirsch, and F. M. Faraci
Potent {varsigma}1-Receptor Ligand 4-Phenyl-1-(4-Phenylbutyl) Piperidine Modulates Basal and N-Methyl-D-Aspartate–Evoked Nitric Oxide Production In Vivo • Editorial Comment
Stroke, November 1, 1998; 29(11): 2404 - 2411.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Poulopoulou and L. M. Nowak
Extracellular 3',5' Cyclic Guanosine Monophosphate Inhibits Kainate-Activated Responses in Cultured Mouse Cerebellar Neurons
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 99 - 109.
[Abstract] [Full Text]


Home page
StrokeHome page
G. Yang, C. Iadecola, and F. M. Faraci
Activation of Cerebellar Climbing Fibers Increases Cerebellar Blood Flow : Role of Glutamate Receptors, Nitric Oxide, and cGMP • Editorial Comment: Role of Glutamate Receptors, Nitric Oxide, and cGMP
Stroke, February 1, 1998; 29(2): 499 - 508.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Pu, T. L. Horvath, S. Diano, F. Naftolin, P. S. Kalra, and S. P. Kalra
Evidence Showing That {beta}-Endorphin Regulates Cyclic Guanosine 3',5'-Monophosphate (cGMP) Efflux: Anatomical and Functional Support for an Interaction between Opiates and Nitric Oxide
Endocrinology, April 1, 1997; 138(4): 1537 - 1543.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. A. Williams, S. R. Vincent, and P. B. Reiner
Nitric Oxide Production in Rat Thalamus Changes with Behavioral State, Local Depolarization, and Brainstem Stimulation
J. Neurosci., January 1, 1997; 17(1): 420 - 427.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-